NEO LARYNGOBIS ENF DIN 00065919
Status: Cancelled Post Market
Holder: LAB BIO CHIMIQUE INC.,DIVISION OF TECHNILAB PHARMA INC.
Molecule: BISMUTH DIPROPYLACETATE
Health Canada record
| Active ingredient(s) | BISMUTH DIPROPYLACETATE 67.5 MG |
|---|---|
| Dosage form | Suppository |
| Route | Rectal |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | R02AA20 VARIOUS |
| Original market date | 31-Dec-1950 |
| Current status date | 22-Aug-1997 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BISMUTH DIPROPYLACETATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00065927 | NEO-LARYNGOBIS | TEVA CANADA LIMITED | Suppository | BISMUTH DIPROPYLACETATE 135 MG | Marketed |